Mühlig, A.K.; Lee, J.Y.; Kemper, M.J.; Kronbichler, A.; Yang, J.W.; Lee, J.M.; Shin, J.I.; Oh, J.
Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects. J. Clin. Med. 2019, 8, 860.
https://doi.org/10.3390/jcm8060860
AMA Style
Mühlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J.
Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects. Journal of Clinical Medicine. 2019; 8(6):860.
https://doi.org/10.3390/jcm8060860
Chicago/Turabian Style
Mühlig, Anne K., Jun Young Lee, Markus J. Kemper, Andreas Kronbichler, Jae Won Yang, Jiwon M. Lee, Jae Il Shin, and Jun Oh.
2019. "Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects" Journal of Clinical Medicine 8, no. 6: 860.
https://doi.org/10.3390/jcm8060860
APA Style
Mühlig, A. K., Lee, J. Y., Kemper, M. J., Kronbichler, A., Yang, J. W., Lee, J. M., Shin, J. I., & Oh, J.
(2019). Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects. Journal of Clinical Medicine, 8(6), 860.
https://doi.org/10.3390/jcm8060860